Literature DB >> 19013766

Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference.

Dan Turner1, Holger J Schünemann, Lauren E Griffith, Dorcas E Beaton, Anne M Griffiths, Jeffrey N Critch, Gordon H Guyatt.   

Abstract

OBJECTIVE: We compared the minimal important difference (MID) values obtained by the receiver operating characteristics (ROC) curve approach using different strategies on four outcome measures to guide the optimal use of ROC curve. STUDY DESIGN AND
SETTING: Studies of two psychometric scales (Rhinoconjunctivitis Quality-of-Life Questionnaire [RQLQ] and Chronic Respiratory Questionnaire [CRQ]) and two clinimetric indices (Pediatric Ulcerative Colitis Activity Index [PUCAI] and Pediatric Crohn's Disease Activity Index [PCDAI]) instruments provided prospective longitudinal data. The MID was calculated from 7- and 15-point global ratings of change dichotomized in multiple ways, using the ROC curve method. Analysis was performed twice: first, using only the two groups adjacent to the dichotomization point (e.g., including only patients who had a small vs. moderate change); and second, using the entire cohort split at the same cutoff (e.g., including both unchanged subjects with those with small change vs. those who experienced moderate or large change combined).
RESULTS: Using the entire cohort, rather than just those with ratings adjacent to the dichotomization point, yielded more precise and sensible MID estimates. With one exception, high precision was obtained when using the ROC curve method for any cutoff on the rating scale.
CONCLUSION: When calculating the MID using the ROC curve method, the use of the entire cohort maximizes precision.

Entities:  

Mesh:

Year:  2008        PMID: 19013766     DOI: 10.1016/j.jclinepi.2008.07.009

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  27 in total

1.  Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness.

Authors:  Michael M Ward; Lori C Guthrie; Maria I Alba
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

Review 2.  Quality of life outcomes after functional endoscopic sinus surgery.

Authors:  Zachary M Soler; Timothy L Smith
Journal:  Otolaryngol Clin North Am       Date:  2010-06       Impact factor: 3.346

3.  Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials.

Authors:  Michael M Ward; Lori C Guthrie; Maria I Alba
Journal:  Ann Rheum Dis       Date:  2014-05-01       Impact factor: 19.103

4.  Performance of an item response theory-based computer adaptive test in identifying functional decline.

Authors:  Andrea L Cheville; Kathleen J Yost; Dirk R Larson; Katiuska Dos Santos; Megan M O'Byrne; Megan T Chang; Terry M Therneau; Felix E Diehn; Ping Yang
Journal:  Arch Phys Med Rehabil       Date:  2012-02-25       Impact factor: 3.966

5.  Responsiveness to change and interpretability of the simplified psoriasis index.

Authors:  Leena Chularojanamontri; Christopher E M Griffiths; Robert J G Chalmers
Journal:  J Invest Dermatol       Date:  2013-07-29       Impact factor: 8.551

6.  Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice.

Authors:  Jennifer L Dotson; Wallace V Crandall; Peixin Zhang; Christopher B Forrest; L Charles Bailey; Richard B Colletti; Michael D Kappelman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-02       Impact factor: 2.839

7.  Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS).

Authors:  James Twiss; Lynda C Doward; Stephen P McKenna; Benjamin Eckert
Journal:  Health Qual Life Outcomes       Date:  2010-10-11       Impact factor: 3.186

8.  The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change.

Authors:  Richard J Swartz; Carolyn Schwartz; Ethan Basch; Li Cai; Diane L Fairclough; Lori McLeod; Tito R Mendoza; Bruce Rapkin
Journal:  Qual Life Res       Date:  2011-02-19       Impact factor: 4.147

9.  Exploration of the methods of establishing the minimum clinical important difference based on anchor and its application in the quality of life measurement scale QLICP-ES (V2.0) for esophageal cancer.

Authors:  Dandan Ren; Ting Wu; Chonghua Wan; Gaofeng Li; Yanbo Qi; Yujing Fang; Jiudi Zhong
Journal:  Health Qual Life Outcomes       Date:  2021-07-02       Impact factor: 3.186

10.  Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT).

Authors:  Quang A Le; Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Health Qual Life Outcomes       Date:  2013-04-12       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.